Biopure Corporation was a biopharmaceutical company that specialized in oxygen therapeutics (blood substitutes) for both human and veterinary use. Unable to obtain FDA approval for Hemopure to date, Biopure ceased operations in 2009 and its assets were purchased by OPK Biotech LLC in September 2009. …
Who owns Biopure?
Brandon Kinder
Since its launch in Spring 2016, bioPURE has keeping homes, offices and families clean with a safe and non-toxic technology. Now let’s go meet the owner, Brandon Kinder (and his family) of bioPURE. 360: How did the idea of bioPure come to life? Brandon: My background is in medical sales.
Is Oxyglobin still available?
Since Oxyglobin® is no longer available, we believe that the potential veterinary market for OXYFEX™ in the U.S., EU and Japan could exceed $250 million in sales annually within five years after introduction.
Is Hemopure FDA approved?
In the US, Hemopure is an investigational new drug that is not approved by the FDA as being safe or effective for any use in humans, and therefore only available through a clinical trial, or expanded access (sometimes called compassionate use).
How much does artificial blood cost?
Hospitals can buy blood for as little as $50 a unit at times but the total costs have been estimated to run at about $175 to $200 a unit, not counting the cost of deaths and disease arising from misuse.
What is PolyHeme?
PolyHeme (Northfield Laboratories Inc., Evanston, Ill) is a first-generation pyridoxylated polymerized hemoglobin made from outdated human blood. It is one of the few products currently being evaluated in a phase III clinical trial that is enrolling patients.
What is bioPURE?
bioPURE™ uses a hospital-type disinfectant that is effective against most common germs, bacteria, and viruses* in your home. Our treatments have also been proven effective against many common household allergens. So, let bioPURE help make your home a healthier environment.
Is root canal bioPURE necessary?
In another study, Mohammadi and Shahriari [28] compared the antimicrobial effect of Biopure MTAD, 2% chlorhexidine and 2.6% NaOCl on E. faecalis in human root dentin. Their findings showed the BioPure MTAD was more effective than the other solutions, and was retained in the root canal dentin for at least 28 days.
What is Oxyglobin veterinary?
Oxyglobin is used to increase the oxygen content of the blood in dogs with anaemia (low red-blood-cell count). Oxyglobin should be used for at least 24 hours. Oxyglobin is first warmed to 37°C, then given to the dog as 30 ml per kilogram body weight, administered at a rate of up to 10 ml/kg per hour.
What is Hemopure made of?
Hemopure is made from chemically stabilized, cross-linked cow hemoglobin using a fairly simple and less expensive biotechnology than required for other HBOC blood substitutes. Its minute size – not more than 1/1000 the size of RBCs – is advantageous for transporting oxygen into small spaces between cells.
Is PolyHeme artificial blood?
New Study Blasts FDA for Allowing Human Testing of Risky Artificial Blood. Blood substitutes, such as Polyheme, up the risks of heart attacks and death.
What are the disadvantages to using artificial blood?
Immune reactions to the blood. Risk of infections. Donor blood must match the blood type of the recipient. Blood must be refrigerated, and has a shelf-life of 42 days, while artificial blood products in development can be freeze-dried and stored at room temperature for up to two years.
What is the business model of biobiopure Corporation?
Biopure Corporation has been operating in two markets, one is the Veterinary market and the other is the Human market. In the human blood market, more than 14 million units of the Red blood cells are actually made available through his donations of blood from different people.
What happened to Biopure biotech?
On July 16, 2009 Biopure announced it had filed for bankruptcy protection under Chapter 11, Title 11, United States Code and entered into an agreement with OPK Biotech LLC for the sale of substantially all of its assets.
What is Biopure’s competitive advantage?
The two products offered by Biopure have their respective competitive advantage of being low cost (John, 1999). Oxyglobin has already achieved the FDA approval and the company has been planning about its prices, release dates and the effect of its introduction in the market.
Is Biopure’s Oxyglobin a profitable product?
In contrast, its Oxyglobin product enjoyed a fairly steady strategy, as Biopure consistently marketed the product mostly to small animal veterinarians. Unfortunately the small market size made turning a profit, especially ex-US, difficult.
